DAWN Jeremy Bender sells $179K worth of shares
Feb 19, 2026, 5:37 AM
0.00%
What does DAWN do
Day One Biopharmaceuticals, based in Brisbane, California, focuses on developing cancer treatments, including its lead candidate tovorafenib. The company went public on May 27, 2021, and employs 174 people.
Jeremy Bender sold 15,459 shares of DAWN on 17 February at $11.60 per share, worth a total of $179K. They now own 204,603 DAWN shares, or a 7% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.